Serum levels of 14-3-3 eta are associated with increased disease risk, activity and duration of rheumatoid arthritis in Chinese patients

doi:10.3892/etm.2020.8761

科研成果详情

题名	Serum levels of 14-3-3 eta are associated with increased disease risk, activity and duration of rheumatoid arthritis in Chinese patients
作者	Tu, Jianxin1; Chen, Xiaowei 1; Dai, Meijie2; Pan, Axiao 1; Liu, Cailong3; Zhou, Yan 1; Xia, Xiaoru1; Sun, Li1
发表日期	2020-08
发表期刊	EXPERIMENTAL AND THERAPEUTIC MEDICINE 影响因子和分区
语种	英语
原始文献类型	Article
关键词	rheumatoid arthritis 14-3-3 eta disease risk disease activity disease duration Chinese
其他关键词	C-REACTIVE PROTEIN ; JOINT DAMAGE ; INFLAMMATION ; PROGRESSION ; ALPHA
摘要	The aim of the present study was to determine the association between serum 14-3-3 eta expression levels and disease risk, inflammation level and disease duration in Chinese patients with rheumatoid arthritis (RA). A total of 45 Chinese patients with RA, 45 patients with osteoarthritis (OA) and 44 age- and sex-matched (with the RA group) healthy control (HC) subjects were consecutively recruited for the present case-controlled study. In addition, the demographic and clinicopathological characteristics of the patients with RA were collected. Serum samples were obtained from patients with RA, patients with OA and the HCs, and the serum levels of 14-3-3 eta were determined by ELISA. Compared with that in the OA patients (P=0.006) and HCs (P<0.001), 14-3-3 eta expression was significantly increased in RA patients, and receiver operating characteristics (ROC) analysis indicated that it served as a potential predictive marker for the risk of RA. In patients with RA, serum levels of 14-3-3 eta were positively correlated with disease duration (P=0.003), erythrocyte sedimentation rate (P=0.006) and disease activity score in 28 joints (P=0.025). The proportion of rheumatoid factor (RF)-positive patients (P=0.023) and anti-citrullinated protein antibody (ACPA)-positive patients (P=0.002) with RA was increased (when 14-3-3 eta expression was increased) compared with RF-negative patients or ACPA-negative patients, respectively. Of note, 14-3-3 eta serum levels were able to distinguish patients with established RA (disease duration, >2 years) from patients with early RA (disease duration, <= 2 years) with an AUC of 0.759 (95% CI, 0.612-0.905), and the sensitivity and the specificity at the best cut-off point (14-3-3 eta=0.613 ng/ml) were 79.3 and 75.0%, respectively. Furthermore, 14-3-3 eta was able to differentiate between RF-positive RA patients and RF-negative patients or HCs. In conclusion, circulating 14-3-3 eta expression may serve as a novel biomarker for disease risk and activity of RA in Chinese patients.
资助项目	Science and Technology Project of Wenzhou [Y20170060, Y20170056]; Science and Technology Action Plan for Major Disease Control-Trauma Repair Special Project, National Health and Family Planning Commission Medical Science and Technology Development Research Center [ZX-01-C2016029]
出版者	SPANDIDOS PUBL LTD
出版地	ATHENS
ISSN	1792-0981
EISSN	1792-1015
卷号	20 期号:2 页码:754-761
DOI	10.3892/etm.2020.8761
页数	8
WOS类目	Medicine, Research & Experimental
WOS研究方向	Research & Experimental Medicine
WOS记录号	WOS:000562806200008
收录类别	SCIE ; PUBMED
URL	查看原文
PubMed ID	32742321
PMC记录号	PMC7388387
通讯作者地址	[Xia, Xiaoru;Sun, Li]Wenzhou Med Univ, Dept Rheumatol & Immunol, Affiliated Hosp 1, 2 Fuxue Lane, Wenzhou 325000, Zhejiang, Peoples R China.
引用统计	被引频次：1[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/14301
专题	附属第一医院_风湿免疫科检验医学院（生命科学学院、生物学实验教学中心）
通讯作者	Xia, Xiaoru; Sun, Li
作者单位	1.Wenzhou Med Univ, Dept Rheumatol & Immunol, Affiliated Hosp 1, 2 Fuxue Lane, Wenzhou 325000, Zhejiang, Peoples R China; 2.Wenzhou Med Univ, Dept Lab Med, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China; 3.Wenzhou Med Univ, Dept Orthopaed Sports Med, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
第一作者单位	附属第一医院; 风湿免疫科
通讯作者单位	附属第一医院; 风湿免疫科
第一作者的第一单位	附属第一医院
推荐引用方式 GB/T 7714	Tu, Jianxin,Chen, Xiaowei,Dai, Meijie,et al. Serum levels of 14-3-3 eta are associated with increased disease risk, activity and duration of rheumatoid arthritis in Chinese patients[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE,2020,20(2):754-761.
APA	Tu, Jianxin., Chen, Xiaowei., Dai, Meijie., Pan, Axiao., Liu, Cailong., ... & Sun, Li. (2020). Serum levels of 14-3-3 eta are associated with increased disease risk, activity and duration of rheumatoid arthritis in Chinese patients. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 20(2), 754-761.
MLA	Tu, Jianxin,et al."Serum levels of 14-3-3 eta are associated with increased disease risk, activity and duration of rheumatoid arthritis in Chinese patients".EXPERIMENTAL AND THERAPEUTIC MEDICINE 20.2(2020):754-761.